secwatch.observer — SEC 8-K summary
======================================

Issuer:     LB PHARMACEUTICALS INC (LBRX)
CIK:        0001691082
Form:       8-K
Filed at:   2026-07-29T12:05:29+00:00
Accession:  0001193125-26-322208
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LB Pharmaceuticals raises $150M in private placement for pipeline expansion
---------------------------------------------------------------------------

- Gross proceeds of ~$150M from sale of 3,577,560 shares at $34.94 and pre-funded warrants for 715,513 shares.
- Proceeds to fund LB-102 expansion into negative symptoms of schizophrenia and Alzheimer's agitation/psychosis.
- Investors include Adage Capital, BB Biotech, Caligan, Commodore, Deep Track, Farallon, Janus Henderson, and others.
- Placement agents: Leerink Partners and Piper Sandler; expected close July 30, 2026.
- Registration rights agreement to file resale registration statement within 90 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526322208/0001193125-26-322208-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1691082/000119312526322208/d156920d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-322208

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer